Efficacy and safety of first-line treatments for patients with advanced anaplastic lymphoma kinase mutated, non-small cell cancer: A systematic review and network meta-analysis

Peng, Y; Zhao, Q; Liao, ZY; Ma, YY; Ma, DY

Ma, DY (通讯作者),North Sichuan Med Coll, Affiliated Hosp, Dept Oncol, 1 Maoyuan South Rd, Nanchong 637000, Sichuan, Peoples R China.

CANCER, 2023; 129 (8): 1261

Abstract

BackgroundThis study compares the safety and efficacy of first-line treatments for anaplastic lymphoma kinase (ALK)-mutated non-small cell lung cancer......

Full Text Link